Basel Assaf at ACT 47th Annual Meeting

Attentive Science is pleased to be part of the American College of Toxicology 47th Annual Meeting. Basel Assaf, BVSc, PhD, DACVP, DABT, FIATP, Vice President, Toxicology & Pathology Services at Attentive Science Ltd – UAE, will present:

Mechanism-Driven Strategies for Translational Safety Success in Gene Therapy
Monday, November 16, 2026 · 2:40 – 3:15 PM CT
Session: In Vivo Gene Therapies: Breakthrough Innovations, Regulatory Roadmaps, and Development Challenges (2:00 – 5:00 PM)

Basel will discuss how understanding the mechanisms behind safety findings helps gene therapy programs move from nonclinical studies to the clinic with confidence.

Attending BACT? Join the session or contact our team to arrange a meeting in San Antonio at Booth #211.